This HTML5 document contains 145 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
n10	http://dx.doi.org/10.1093/ANNONC/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q34737119

rdf:type

wikibase:Item

schema:description

vitenskapelig artikkel vědecký článek artículo científico publicado en 2014 2014 թվականի հունվարին հրատարակված գիտական հոդված 2014年の論文 wetenschappelijk artikel vedecký článok article científic наукова стаття, опублікована в січні 2014 мақолаи илмӣ vetenskaplig artikel 2014 nî lūn-bûn научни чланак artigo científico 2014年论文 vitskapeleg artikkel 2014年論文 artikull shkencor article scientific articolo scientifico 2014년 논문 2014年论文 teaduslik artikkel научна статия 2014年论文 artículu científicu espublizáu en 2014 artykuł naukowy article scientifique (publié 2014) 2014年論文 bài báo khoa học mokslinis straipsnis سائنسی مضمون naučni članak 2014年论文 2014年論文 επιστημονικό άρθρο 2014 թուականի Յունուարին հրատարակուած գիտական յօդուած artikulong pang-agham مقالة علمية 2014年论文 artigo científico (publicado na 2014) מאמר מדעי articol științific ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научная статья bilimsel makale 2014年论文 scientific article wissenschaftlicher Artikel مقالهٔ علمی სამეცნიერო სტატია artigo científico (publicado na 2014) scienca artikolo tieteellinen artikkeli 2014年論文 мақолаи илмӣ videnskabelig artikel (udgivet 2014) научни чланак บทความทางวิทยาศาสตร์ 2014年論文 tudományos cikk

p:P577

wds:Q34737119-EE5AC2B5-D0B8-402F-896E-0B6D863F2492

wdt:P577

2014-01-01T00:00:00Z

p:P2860

wds:Q34737119-D9920436-52E9-4DB2-AAD7-064CFD418712 wds:Q34737119-DD0AFF10-BFD1-425F-9DCB-63D725B3DD15 wds:Q34737119-DF962445-85C7-45CF-ACB3-CB7AF0FD2B4E wds:Q34737119-8A0DAF07-32EE-4895-9D28-E894AB52424A wds:Q34737119-B5F372B3-F5D3-43C4-B7DA-763F8A509BA5 wds:Q34737119-C0192E2D-6C55-4BF2-8AA1-CC7333CF4FC4 wds:Q34737119-01DB39B4-1206-43F9-B7DC-56BA8D9943E4 wds:Q34737119-0EDD7FEC-8B4E-4A3D-8E26-45E8C4F45A3C wds:Q34737119-7459FB77-846E-4F67-9CB4-0A79DC85B2FF wds:Q34737119-2C0CF0FA-921C-49A7-9F2C-815F78518118 wds:Q34737119-3BC9F8AE-F0E5-46C2-8F67-FA89A7E21561 wds:Q34737119-59AB5E11-35EB-4615-AFFD-308A04E612CD

wdt:P2860

wd:Q36532675 wd:Q36910431 wd:Q54599564 wd:Q35854811 wd:Q54493173 wd:Q81675946 wd:Q44917352 wd:Q46897600 wd:Q35350491 wd:Q73492613 wd:Q34656740 wd:Q34645665

p:P2093

wds:Q34737119-9939E052-F5DD-45C3-B140-E1D008C62964 wds:Q34737119-A106C688-54BD-4E1E-BC57-D58BB025F7BD wds:Q34737119-86BD700E-0D69-4136-A832-F56D7BAAC088 wds:Q34737119-81321100-0646-4854-8949-F3F689404F34 wds:Q34737119-86B0ECC5-D6C1-4879-B4F0-ED40B0F221E8 wds:Q34737119-7FE41A1A-DA6A-4C68-A1BF-538A8E2AAA98 wds:Q34737119-5DA82E41-7304-4B1C-ADD9-00FECFC774C9 wds:Q34737119-38B9BBC5-5B3D-4A51-9493-177681950E48 wds:Q34737119-1BD51A75-87FC-4B53-8E68-E3543466505D wds:Q34737119-10F1A99E-0832-4A2E-B713-573AD82C75A5 wds:Q34737119-EAAA8594-549E-413E-916E-3D8A3BBAEBC2

wdt:P2093

J E Butrynski A J Wagner D D'Adamo G D Demetri A McMillan S George V M Villalobos A Kamaya J A Morgan G A Fisher K N Ganjoo

rdfs:label

A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors

skos:prefLabel

A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors

schema:name

A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib

p:P1476

wds:Q34737119-38C2BB1C-28A0-48FC-A40B-7B001F05EBBA

wdt:P1476

A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib

p:P304

wds:Q34737119-090BA4DC-5DCC-4EC5-9470-C467143F7E3D

wdt:P304

236-240

p:P31

wds:Q34737119-CC2B18C5-AF03-44C9-A579-634AE1E4917C

wdt:P31

wd:Q13442814

p:P921

wds:Q34737119-EB406DFB-8ECC-40A1-8749-1B41D05B4C6A wds:Q34737119-6FBD5F14-D346-450C-9F27-A3F381A60BD7

wdt:P921

wd:Q6934595 wd:Q177094

p:P698

wds:Q34737119-DCD76FCA-0F9A-426C-9599-E1B979A61A5D

wdtn:P698

n11:24356634

wdt:P698

24356634

p:P1433

wds:Q34737119-1D68DD41-7C2E-4A88-BFDA-855164522FC3

wdt:P1433

wd:Q326122

p:P433

wds:Q34737119-3182557E-D600-4ED1-8899-727C3DA4DF3D

p:P478

wds:Q34737119-16BE4ED5-A918-401B-9072-A1B5FA2E5A85

wdt:P433

1

wdt:P478

25

p:P356

wds:Q34737119-6D562984-2542-4F05-9ACC-C60214777345

wdtn:P356

n10:MDT484

wdt:P356

10.1093/ANNONC/MDT484

p:P5875

wds:Q34737119-59FE41EF-BC54-4514-8008-F01078CCFA2E

wdt:P5875

259394817

p:P932

wds:Q34737119-D4272B9C-E7EB-456E-8BAB-C275F72C3229

wdt:P932

4271129